DEF: Unicycive Therapeutics Seeks Stockholder Approval for Reverse Stock Split at Upcoming Annual Meeting

Unicycive Therapeutics is holding its annual meeting on June 9, 2025, seeking stockholder approval for key proposals including a reverse stock split to maintain its Nasdaq listing and the election of directors.

Summary

• Unicycive Therapeutics will hold its annual meeting of stockholders on June 9, 2025, at its Los Altos, CA offices.
• Stockholders will vote on the election of four directors, ratification of Grassi & Co. as the independent accounting firm for fiscal year 2025, and a reverse stock split proposal.
• The proposed reverse stock split would consolidate shares at a ratio between 1-for-2 and 1-for-20, with the final ratio determined by the board within one year of the meeting.
• The board believes a reverse stock split is necessary to maintain the minimum bid price requirement for continued listing on the Nasdaq Capital Market.
• As of April 30, 2025, there were 120,629,281 shares of common stock outstanding, along with 5,464.21 shares of Series A Preferred Stock and 3,000 shares of Series B Preferred Stock.
• Each share of common stock represents one vote, while preferred stock votes are calculated on an as-if-converted basis, subject to beneficial ownership limitations.
• The aggregate amount of shares eligible to vote at the meeting is 125,525,797.
• The company has retained Alliance Advisors as its strategic shareholder advisor and proxy solicitation agent at an approximate cost of $14,500, plus $5,000 for expenses.
• Stockholder proposals for the 2026 annual meeting must be received by December 21, 2025, to be included in the proxy statement.

Sentiment

Score: 5

Explanation: The document is neutral, primarily conveying information about the upcoming annual meeting and proposals. The need for a reverse stock split indicates underlying financial challenges, but the company is taking steps to address them.

Positives

• The proposed reverse stock split aims to maintain the company's Nasdaq listing, which could improve stock liquidity and attract a broader range of investors.
• The company is committed to good corporate governance practices, including a Code of Business Conduct and Ethics and an insider trading policy.
• The Board of Directors has determined that four of the five incumbent directors are independent.
• The company has established an Audit Committee, a Compensation Committee, and a Nominating and Governance Committee to assist the Board in fulfilling its oversight responsibilities.
• The company maintains a 401(k) plan for its employees, matching contributions up to 4% of eligible compensation.

Negatives

• The company received a notice from Nasdaq indicating that its common stock bid price had closed below the minimum $1.00 per share, necessitating the reverse stock split proposal.
• If the reverse stock split is effected, the post-split market price of the common stock may be less than the pre-split price multiplied by the reverse stock split ratio.
• A reduction in the number of shares outstanding may impair the liquidity of the common stock, which may reduce its value.
• Stockholders may experience further dilution of their ownership due to the effective increase in authorized and unissued shares of common stock.

Risks

• Failure to maintain the minimum bid price requirement could result in delisting from the Nasdaq Capital Market, reducing stock liquidity and potentially lowering the stock price.
• The reverse stock split may not be successful in increasing the stock price or maintaining Nasdaq listing compliance.
• Future issuances of common stock could dilute earnings per share, book value per share, and voting rights of existing stockholders.
• The increased number of authorized shares could be used to deter a potential takeover, which may otherwise be beneficial to stockholders.

Future Outlook

The company aims to maintain its Nasdaq listing through the proposed reverse stock split and is exploring all available strategic options.

Management Comments

• Our Board intends to effect the Reverse Stock Split only if it believes that a decrease in the number of shares outstanding is in the best interests of the Company and our stockholders and is likely to improve the trading price of our Common Stock and improve the likelihood that we will be allowed to maintain our listing on Nasdaq.
• Accordingly, our Board approved the Reverse Stock Split as being in the best interests of the Company.

Industry Context

Reverse stock splits are a common strategy for companies facing delisting from exchanges due to low stock prices, aiming to improve investor perception and attract institutional investment.

Comparison to Industry Standards

• Many companies facing similar Nasdaq listing deficiencies have implemented reverse stock splits, such as Titan Machinery Inc. which implemented a 1-for-10 reverse stock split in 2020.
• Other companies such as BioPharmX, Inc. have failed to regain compliance despite reverse stock splits, highlighting the risk involved.
• The success of a reverse stock split often depends on the company's underlying financial performance and future growth prospects.

Related Party Transactions

• The Company received advances from our Chief Executive Officer and stockholder of $210,000 during February 2023.
• The Company repaid amounts owed to our Chief Executive Officer and stockholder of $210,000 plus approximately $1,000 in accrued interest during March 2023.

Stakeholder Impact

• Stockholders may experience a change in the number of shares they own due to the reverse stock split.
• The reverse stock split aims to improve the company's stock price and maintain its Nasdaq listing, potentially benefiting stockholders.
• Employees and directors may be affected by changes in equity compensation plans due to the reverse stock split.
• The company's ability to raise capital and pursue strategic opportunities could be impacted by the reverse stock split and its effect on the stock price.

Next Steps

• Stockholders to vote on the proposals at the Annual Meeting on June 9, 2025.
• Board of Directors to determine the final ratio for the reverse stock split, if approved.
• Company to file an amendment to the Amended and Restated Certificate of Incorporation with the Secretary of State of Delaware to effect the Reverse Stock Split, if approved.
• Company to notify stockholders of the reverse stock split and provide instructions for exchanging stock certificates.

Key Dates

Keywords

reverse stock split, annual meeting, proxy statement, board of directors, Nasdaq, Grassi & Co., director election, corporate governance, executive compensation, stockholders